/GUARD.ST
GUARD.ST Stock - Guard Therapeutics International AB (publ)
Healthcare|BiotechnologySTO
$1.40-6.04%
$0.09 (-6.04%) • Dec 23
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.54
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GUARD.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.39 – $1.41
TARGET (TP)$1.61
STOP LOSS$1.29
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.34
52W High$34.80
52W Low$1.10
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | $-15,000 | $-15,000 | $-15,000 | $-161,000 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-99,905,000 | $-115,073,000 | $-114,921,000 | $-81,900,000 | $-40,277,000 |
| Net Income | $-96,066,000 | $-113,323,000 | $-110,756,000 | $-82,160,000 | $-40,291,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-8.62 | $-11.26 | $-15.72 | $-0.74 | $-0.26 |
Company Overview
Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
GUARD.STBeat Rate
100%
Last 3 quarters
Avg Surprise
+67.8%
EPS vs Estimate
Beats / Misses
3/0
Last 12 quarters
Latest EPS
$-1.29
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Feb 20, 2026 | — | — | — | — |
Q4 2025 | Nov 13, 2025 | — | $-1.29 | — | — |
Q3 2025 | Aug 21, 2025 | — | $-1.66 | — | — |
Q2 2025 | May 5, 2025 | — | $-2.78 | — | — |
Q1 2025 | Feb 20, 2025 | — | $-2.11 | — | — |
Q4 2024 | Nov 13, 2024 | — | $-2.65 | — | — |
Q3 2024 | Aug 22, 2024 | — | $-2.33 | — | — |
Q2 2024 | May 8, 2024 | — | $-1.44 | — | — |
Q1 2024 | Feb 21, 2024 | — | $-1.70 | — | — |
Q4 2023 | Nov 10, 2023 | — | $-2.32 | — | — |
Q3 2023 | Aug 24, 2023 | — | $-3.28 | — | — |
Q2 2023 | May 9, 2023 | — | $-3.90 | — | — |
Q1 2023 | Feb 22, 2023 | $-5.75 | $-5.42 | +5.8% | ✓ BEAT |
Q4 2022 | Nov 16, 2022 | $-4.79 | $-0.08 | +98.2% | ✓ BEAT |
Q3 2022 | Aug 23, 2022 | — | $-0.06 | — | — |
Q2 2022 | May 12, 2022 | — | $-0.05 | — | — |
Q1 2022 | Feb 22, 2022 | $-9.00 | $-0.07 | +99.3% | ✓ BEAT |
Q4 2021 | Nov 5, 2021 | — | $-0.16 | — | — |
Q3 2021 | Aug 19, 2021 | — | $-0.05 | — | — |
Latest News
Loading news...
Frequently Asked Questions about GUARD.ST
What is GUARD.ST's current stock price?
Guard Therapeutics International AB (publ) (GUARD.ST) is currently trading at $1.40 per share. The stock has moved -6.04% today.
What is the analyst price target for GUARD.ST?
No analyst price targets are currently available for this stock.
What sector is Guard Therapeutics International AB (publ) in?
Guard Therapeutics International AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is GUARD.ST's market cap?
Guard Therapeutics International AB (publ) has a market capitalization of $0.03 billion, making it a small-cap company.
Does GUARD.ST pay dividends?
No, Guard Therapeutics International AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector2CUREX.ST
2cureX AB (publ)
$0.75
Mkt Cap: $0.0B
APTA.ST
Aptahem AB (publ)
$1.12
Mkt Cap: $0.0B
EPIS-B.ST
Episurf Medical AB (publ)
$0.03
Mkt Cap: $0.0B
FLUI.ST
Fluicell AB (publ)
$11.30
Mkt Cap: $0.0B
MODTX.ST
Modus Therapeutics Holding AB (publ)
$0.30
Mkt Cap: $0.0B
ODI.ST
ODI Pharma AB
$3.22
Mkt Cap: $0.1B
PROGEN.ST
Prostatype Genomics AB (publ)
$0.35
Mkt Cap: $0.0B
QLIFE.ST
Qlife Holding AB (publ)
$2.40
Mkt Cap: $0.0B
QUIA.ST
Quia Pharma AB (publ)
$0.00
Mkt Cap: $0.0B
STABL.ST
Stayble Therapeutics AB (publ)
$0.21
Mkt Cap: $0.0B
Explore stocks similar to GUARD.ST for comparison